Cargando…

Phages Needed against Resistant Bacteria

Phages have been known for more than 100 years. They have been applied to numerous infectious diseases and have proved to be effective in many cases. However, they have been neglected due to the era of antibiotics. With the increase of antibiotic-resistant microorganisms, we need additional therapie...

Descripción completa

Detalles Bibliográficos
Autor principal: Moelling, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412541/
https://www.ncbi.nlm.nih.gov/pubmed/32664292
http://dx.doi.org/10.3390/v12070743
_version_ 1783568631975641088
author Moelling, Karin
author_facet Moelling, Karin
author_sort Moelling, Karin
collection PubMed
description Phages have been known for more than 100 years. They have been applied to numerous infectious diseases and have proved to be effective in many cases. However, they have been neglected due to the era of antibiotics. With the increase of antibiotic-resistant microorganisms, we need additional therapies. Whether or not phages can fulfill this expectation needs to be verified and tested according to the state-of-the-art of international regulations. These regulations fail, however, with respect to GMP production of phages. Phages are biologicals, not chemical compounds, which cannot be produced under GMP regulations. This needs to be urgently changed to allow progress to determine how phages can enter routine clinical settings.
format Online
Article
Text
id pubmed-7412541
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74125412020-08-26 Phages Needed against Resistant Bacteria Moelling, Karin Viruses Commentary Phages have been known for more than 100 years. They have been applied to numerous infectious diseases and have proved to be effective in many cases. However, they have been neglected due to the era of antibiotics. With the increase of antibiotic-resistant microorganisms, we need additional therapies. Whether or not phages can fulfill this expectation needs to be verified and tested according to the state-of-the-art of international regulations. These regulations fail, however, with respect to GMP production of phages. Phages are biologicals, not chemical compounds, which cannot be produced under GMP regulations. This needs to be urgently changed to allow progress to determine how phages can enter routine clinical settings. MDPI 2020-07-10 /pmc/articles/PMC7412541/ /pubmed/32664292 http://dx.doi.org/10.3390/v12070743 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Moelling, Karin
Phages Needed against Resistant Bacteria
title Phages Needed against Resistant Bacteria
title_full Phages Needed against Resistant Bacteria
title_fullStr Phages Needed against Resistant Bacteria
title_full_unstemmed Phages Needed against Resistant Bacteria
title_short Phages Needed against Resistant Bacteria
title_sort phages needed against resistant bacteria
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412541/
https://www.ncbi.nlm.nih.gov/pubmed/32664292
http://dx.doi.org/10.3390/v12070743
work_keys_str_mv AT moellingkarin phagesneededagainstresistantbacteria